IL13 and irritable bowel syndrome: Stimulation with A. muciniphila, a bacterium that is considered to have beneficial metabolic effects for the host [14], resulted only in a tendency to increased release of the anti-inflammatory cytokine IL-13 in PI-IBS patients compared to healthy controls (Fig 1b).